Tag: Life Sciences

0
Import improvements in JMP Genomics 6

During every release cycle, the JMP Genomics development team adds support for new data types and updates our existing import processes to work with the latest formats. We can bring in many types of raw or summarized data files from next-gen sequencing studies and microarray experiments.  These files are imported into

0
JMP Genomics 6 released

We’re pleased to announce that JMP Genomics 6 is now available! Work on this update has been in progress since JMP Genomics 5.1 came out late last year, and this is our first JMP Genomics version built on the JMP 10 platform released this spring. During this release cycle, as

0
JMP Life Sciences at Joint Statistical Meetings 2012

With more than 6,000 attendees, the Joint Statistical Meetings (JSM) is the largest gathering of statisticians held in North America.  This year, the event takes place from July 28 to Aug. 2 in San Diego, California. Developers from JMP Life Sciences will be on hand at the JMP booth in

1
Disproportionality analysis is coming in JMP Clinical 4.0

While randomized clinical trials are the gold standard for evaluating the efficacy of a new intervention, the available sample size is often insufficient to fully understand its safety profile. The risk a new therapy may pose may not be well understood until it has been on the market for many

0
JMP Clinical at CDISC European Interchange

Every year, the Clinical Data Interchange Standards Consortium (CDISC) holds several Interchange events that take place in the US, Europe and Asia. These meetings have several goals: to give CDISC users the opportunity to present solutions to data challenges that arise in the day-to-day use of these standards; to provide new or

0
JMP Genomics shows the future of biomarker discovery

The Biomarkers Congress is Europe’s largest biomarkers event showcasing case studies in biomarker discovery, and validation strategies and regulation. Its industry delegate list reads like a who’s who in the world of biomarkers, with representation from throughout the globe, for example, AstraZeneca, GSK, Merck, Roche and Takeda. It was fantastic

0
JMP Genomics at Plant & Animal Genomes meeting

The JMP booth at the Plant and Animal Genomes (PAG) meeting was a constant blur of activity this week in San Diego. Over three days, we talked with more than 100 researchers, all working to improve our knowledge of many different kinds of plants and animals. We talked with scientists

0
JMP Clinical present at PhUSE, Brighton 2011

The Pharmaceutical Users Software Exchange (PhUSE) conference in the British seaside resort of Brighton was nearly two months ago, but I am still thinking about it; PhUSE provided an opportunity to learn from experts and share ideas about the application of software in the pharmaceutical industry. The theme for this

0
Accounting for the time at which an adverse event occurs

In a previous post, I described how JMP Clinical allows you to specify time windows within an incidence analysis. Specifying time windows can provide a more informative analysis since it is possible to view how the risk of adverse events (AEs) changes over the course of a clinical trial. However, the

2
Customizing and extending analytics with add-ins

Wayne Levin is part of a group of engineers, statisticians and programmers who are passionate about expanding the use of statistical methods to improve productivity, quality and yields. That group is Predictum, and Wayne is president. How exactly does Predictum help companies improve productivity, quality and yields? "We do this